A new study reports for the first time that injection of neuropeptide vasoactive intestinal peptide (VIP) directly into the eye of mice enhanced corneal graft survival. A new study in the American ...
Kudo, T., Tahara, Y., Gamble, K.L., McMahon, D.G., Block, G.D., and Colwell, C.S. (2013). Vasoactive intestinal peptide produces long-lasting changes in neural ...
The study of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) has expanded markedly over recent decades, establishing these neuropeptides as pivotal ...
Use of vasoactive intestinal peptide (VIP) to treat critical COVID-19 respiratory failure in patients with comorbidities has shown promise. Researchers presented findings from a prospective, ...
Therapy with immune checkpoint inhibitors has become a new therapeutic option for several types of cancer, but immune-related adverse events can limit their use. 1 Outside of clinical studies, ...
Please provide your email address to receive an email when new articles are posted on . Increased serum vasoactive intestinal peptide levels appeared associated with acute exacerbation of chronic ...
Neurons in the brain's master clock that adjust their activity in response to light have a key role in the resetting of an animal's daily cycle, finds a study of male and female mice published in ...
Results in an animal study suggest that vasoactive intestinal peptide may provide a new strategy for improving the outcomes of corneal transplant surgery, reports The American Journal of Pathology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results